289 related articles for article (PubMed ID: 34522174)
21. Upregulation Of Protein Tyrosine Phosphatase Receptor Type C Associates To The Combination Of Hashimoto's Thyroiditis And Papillary Thyroid Carcinoma And Is Predictive Of A Poor Prognosis.
Wu Y; Han J; Vladimirovna KE; Zhang S; Lv W; Zhang Y; Jamaspishvili E; Sun J; Fang Q; Meng J; Qiao H
Onco Targets Ther; 2019; 12():8479-8489. PubMed ID: 31686862
[TBL] [Abstract][Full Text] [Related]
22. Integrative Analysis of Potential Biomarkers Involved in the Progression of Papillary Thyroid Cancer.
Bansal R; Saxena U
Appl Biochem Biotechnol; 2023 May; 195(5):2917-2932. PubMed ID: 36445679
[TBL] [Abstract][Full Text] [Related]
23. Altered profile of glycosylated proteins in serum samples obtained from patients with Hashimoto's thyroiditis following depletion of highly abundant proteins.
Xu Y; Huo J; Nie R; Ge L; Xie C; Meng Y; Liu J; Wu L; Qin X
Front Immunol; 2023; 14():1182842. PubMed ID: 37457741
[TBL] [Abstract][Full Text] [Related]
24. IL-10 Restores MHC Class I Expression and Interferes With Immunity in Papillary Thyroid Cancer With Hashimoto Thyroiditis.
Lu ZW; Hu JQ; Liu WL; Wen D; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32348468
[TBL] [Abstract][Full Text] [Related]
25. Special role of JUN in papillary thyroid carcinoma based on bioinformatics analysis.
Chen W; Liu Q; Lv Y; Xu D; Chen W; Yu J
World J Surg Oncol; 2017 Jul; 15(1):119. PubMed ID: 28673327
[TBL] [Abstract][Full Text] [Related]
26. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis.
Han LT; Hu JQ; Ma B; Wen D; Zhang TT; Lu ZW; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
Diagn Pathol; 2019 Jun; 14(1):52. PubMed ID: 31159823
[TBL] [Abstract][Full Text] [Related]
27. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
[TBL] [Abstract][Full Text] [Related]
28. Genomic evidence of reactive oxygen species elevation in papillary thyroid carcinoma with Hashimoto thyroiditis.
Yi JW; Park JY; Sung JY; Kwak SH; Yu J; Chang JH; Kim JH; Ha SY; Paik EK; Lee WS; Kim SJ; Lee KE; Kim JH
Endocr J; 2015; 62(10):857-77. PubMed ID: 26211532
[TBL] [Abstract][Full Text] [Related]
29. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
Zhao H; Li H
Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265
[TBL] [Abstract][Full Text] [Related]
30. The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease.
Zhang L; Li H; Ji QH; Zhu YX; Wang ZY; Wang Y; Huang CP; Shen Q; Li DS; Wu Y
BMC Cancer; 2012 Dec; 12():610. PubMed ID: 23256514
[TBL] [Abstract][Full Text] [Related]
31. Bioinformatics analysis of key genes and pathways in Hashimoto thyroiditis tissues.
Zheng L; Dou X; Song H; Wang P; Qu W; Zheng X
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32662826
[TBL] [Abstract][Full Text] [Related]
32. Bioinformatics and Connectivity Map Analysis Suggest Viral Infection as a Critical Causative Factor of Hashimoto's Thyroiditis.
Lim DW; Choi MS; Kim SM
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674671
[TBL] [Abstract][Full Text] [Related]
33. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Liu Y; Lv H; Zhang S; Shi B; Sun Y
Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of lncRNA-mediated ceRNA network in papillary thyroid cancer.
Sun Y; Dai WR; Xia N
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10003-10014. PubMed ID: 33090405
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive Identification of Potential Crucial Genes and miRNA-mRNA Regulatory Networks in Papillary Thyroid Cancer.
Nan BY; Xiong GF; Zhao ZR; Gu X; Huang XS
Biomed Res Int; 2021; 2021():6752141. PubMed ID: 33521130
[TBL] [Abstract][Full Text] [Related]
36. The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma.
Zhang Y; Dai J; Wu T; Yang N; Yin Z
J Cancer Res Clin Oncol; 2014 Jun; 140(6):1021-6. PubMed ID: 24619663
[TBL] [Abstract][Full Text] [Related]
37. Integrated bioinformatics analysis and screening of hub genes in papillary thyroid carcinoma.
Fan R; Dong L; Li P; Wang X; Chen X
PLoS One; 2021; 16(6):e0251962. PubMed ID: 34115774
[TBL] [Abstract][Full Text] [Related]
38. Papillary thyroid carcinoma in children with Hashimoto's thyroiditis - a review of the literature between 2000 and 2020.
Sur ML; Gaga R; Lazăr C; Lazea C; Aldea C; Sur D
J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1511-1517. PubMed ID: 33180046
[TBL] [Abstract][Full Text] [Related]
39. Hashimoto's thyroiditis and papillary thyroid carcinoma. Are cytokeratin 19 and P63 proteins of any diagnostic value?
Divani SN; Kalodimos GP; Lioupis MA; Syrmos NC
Hell J Nucl Med; 2016; 19(3):250-253. PubMed ID: 27824965
[TBL] [Abstract][Full Text] [Related]
40. CARD9 gene rs4077515 polymorphism is associated with the susceptibility of Hashimoto's thyroiditis and the development of thyroid cancer.
Zhang L; Yu H; You Q; Rong J; Song C; Sun X
Cancer Epidemiol; 2022 Dec; 81():102273. PubMed ID: 36265241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]